- Home
- CZFS vs INM Comparison
CZFS vs INM Comparison
Compare CZFS & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZFS | INM |
|---|---|---|
| Founded | 1984 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.6M | 3.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CZFS | INM |
|---|---|---|
| Price | $58.66 | $1.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.2K | ★ 145.5K |
| Earning Date | 01-29-2026 | 02-11-2026 |
| Dividend Yield | ★ 3.41% | N/A |
| EPS Growth | ★ 24.64 | N/A |
| EPS | ★ 7.10 | N/A |
| Revenue | ★ $107,399,000.00 | $4,798,116.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.45 | N/A |
| P/E Ratio | $8.26 | ★ N/A |
| Revenue Growth | ★ 9.73 | N/A |
| 52 Week Low | $49.96 | $1.13 |
| 52 Week High | $66.06 | $8.27 |
Technical Indicators
Market Signals| Indicator | CZFS | INM |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 41.64 |
| Support Level | $60.78 | $1.18 |
| Resistance Level | $61.61 | $1.35 |
| Average True Range (ATR) | 2.05 | 0.11 |
| MACD | -0.25 | 0.01 |
| Stochastic Oscillator | 41.93 | 19.44 |
Price Performance
Historical ComparisonAbout CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.